{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:40:24Z","timestamp":1791639624402,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Spinal muscular atrophy (SMA) is a severe neuromuscular disorder caused by loss of the <jats:italic>survival motor neuron 1<\/jats:italic> (<jats:italic>SMN1<\/jats:italic>) gene. SMA is characterized by the degeneration of spinal cord motoneurons (MNs), progressive skeletal muscle atrophy, and weakness. The cellular and molecular mechanisms causing MN loss of function are only partially known. Recent advances in SMA research postulate the role of calpain protease regulating survival motor neuron (SMN) protein and the positive effect on SMA phenotype of treatment with calpain inhibitors. We analyzed the level of calpain pathway members in mice and human cellular SMA models. Results indicate an increase of calpain activity in SMN-reduced MNs. Spinal cord analysis of SMA mice treated with calpeptin, a calpain inhibitor, showed an increase of SMN, calpain, and its endogenous inhibitor calpastatin in MNs. Finally, in vitro calpeptin treatment prevented microtubule-associated protein 1A\/1B-light chain 3 (LC3) increase in MNs neurites, indicating that calpain inhibition may reduce autophagosome accumulation in neuron prolongations, but not in soma. Thus, our results show that calpain activity is increased in SMA MNs and its inhibition may have a beneficial effect on SMA phenotype through the increase of SMN in spinal cord MNs.<\/jats:p>","DOI":"10.1038\/s41419-020-2688-5","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T09:02:32Z","timestamp":1593075752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models"],"prefix":"10.1038","volume":"11","author":[{"given":"Sandra","family":"de la Fuente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Sansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Vivancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Romero-Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garcera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"2688_CR1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.embor.7400941","volume":"8","author":"L Pellizzoni","year":"2007","unstructured":"Pellizzoni, L. Chaperoning ribonucleoprotein biogenesis in health and disease. EMBO Rep. 8, 340\u2013345 (2007).","journal-title":"EMBO Rep."},{"key":"2688_CR2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0092-8674(00)80367-0","volume":"90","author":"Q Liu","year":"1997","unstructured":"Liu, Q., Fischer, U., Wang, F. & Dreyfuss, G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90, 1013\u20131021 (1997).","journal-title":"Cell"},{"key":"2688_CR3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","volume":"163","author":"W Rossoll","year":"2003","unstructured":"Rossoll, W. et al. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J. Cell Biol. 163, 801\u2013812 (2003).","journal-title":"J. Cell Biol."},{"key":"2688_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nurx.2006.01.010","volume":"3","author":"CJ Sumner","year":"2006","unstructured":"Sumner, C. J. Therapeutics development for spinal muscular atrophy. NeuroRx 3, 235\u2013245 (2006).","journal-title":"NeuroRx"},{"key":"2688_CR5","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn, M. R. & Wang, C. H. Spinal muscular atrophy. Lancet 371, 2120\u20132133 (2008).","journal-title":"Lancet"},{"key":"2688_CR6","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","volume":"35","author":"S Tisdale","year":"2015","unstructured":"Tisdale, S. & Pellizzoni, L. Disease mechanisms and therapeutic approaches in spinal muscular atrophy. J. Neurosci. 35, 8691\u20138700 (2015).","journal-title":"J. Neurosci."},{"key":"2688_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre, S. et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155\u2013165 (1995).","journal-title":"Cell"},{"key":"2688_CR8","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson, C. L., Hahnen, E., Androphy, E. J. & Wirth, B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA 96, 6307\u20136311 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2688_CR9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani, U. R. et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177\u20131183 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"2688_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre, S. et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16, 265\u2013269 (1997).","journal-title":"Nat. Genet."},{"key":"2688_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes, A. H. & Beattie, C. E. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10, 597\u2013609 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"2688_CR12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel, R. S. et al. Nusinersen versus Sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723\u20131732 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2688_CR13","doi-asserted-by":"publisher","unstructured":"Al-Zaidy, S. A. et al. AVXS-101 (Onasemnogene Abeparvovec) for SMA1: comparative study with a prospective natural history cohort. J. Neuromuscul. Dis. https:\/\/doi.org\/10.3233\/JND-190403 (2019).","DOI":"10.3233\/JND-190403"},{"key":"2688_CR14","first-page":"4741252","volume":"2019","author":"JJ Weber","year":"2019","unstructured":"Weber, J. J., Pereira Sena, P., Singer, E. & Nguyen, H. P. Killing two angry birds with one stone: autophagy activation by inhibiting calpains in neurodegenerative diseases and beyond. Biomed. Res. Int. 2019, 4741252 (2019).","journal-title":"Biomed. Res. Int."},{"key":"2688_CR15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ceb.2010.10.001","volume":"23","author":"G Marino","year":"2011","unstructured":"Marino, G., Madeo, F. & Kroemer, G. Autophagy for tissue homeostasis and neuroprotection. Curr. Opin. Cell Biol. 23, 198\u2013206 (2011).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2688_CR16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jnc.13536","volume":"137","author":"MV Rao","year":"2016","unstructured":"Rao, M. V., Campbell, J., Palaniappan, A., Kumar, A. & Nixon, R. A. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice. J. Neurochem. 137, 253\u2013265 (2016).","journal-title":"J. Neurochem."},{"key":"2688_CR17","doi-asserted-by":"crossref","first-page":"728571","DOI":"10.5402\/2012\/728571","volume":"2012","author":"A Ferreira","year":"2012","unstructured":"Ferreira, A. Calpain dysregulation in Alzheimer\u2019s disease. ISRN Biochem. 2012, 728571 (2012).","journal-title":"ISRN Biochem."},{"key":"2688_CR18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/187152708784936680","volume":"7","author":"S Samantaray","year":"2008","unstructured":"Samantaray, S., Ray, S. K. & Banik, N. L. Calpain as a potential therapeutic target in Parkinson\u2019s disease. CNS Neurol. Disord. Drug Targets 7, 305\u2013312 (2008).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"2688_CR19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ceb.2009.12.002","volume":"22","author":"K Moreau","year":"2010","unstructured":"Moreau, K., Luo, S. & Rubinsztein, D. C. Cytoprotective roles for autophagy. Curr. Opin. Cell Biol. 22, 206\u2013211 (2010).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2688_CR20","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0086-4","volume":"8","author":"A Piras","year":"2017","unstructured":"Piras, A. et al. Inhibition of autophagy delays motoneuron degeneration and extends lifespan in a mouse model of spinal muscular atrophy. Cell Death Dis. 8, 3223 (2017).","journal-title":"Cell Death Dis."},{"key":"2688_CR21","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1007\/s12035-018-1379-z","volume":"56","author":"S de la Fuente","year":"2019","unstructured":"de la Fuente, S., Sansa, A., Periyakaruppiah, A., Garcera, A. & Soler, R. M. Calpain inhibition increases SMN protein in spinal cord motoneurons and ameliorates the spinal muscular atrophy phenotype in mice. Mol. Neurobiol. 56, 4414\u20134427 (2019).","journal-title":"Mol. Neurobiol."},{"key":"2688_CR22","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1471-4159.2009.06278.x","volume":"110","author":"M Gou-Fabregas","year":"2009","unstructured":"Gou-Fabregas, M. et al. Specific vulnerability of mouse spinal cord motoneurons to membrane depolarization. J. Neurochem. 110, 1842\u20131854 (2009).","journal-title":"J. Neurochem."},{"key":"2688_CR23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nbd.2011.02.003","volume":"42","author":"A Garcera","year":"2011","unstructured":"Garcera, A. et al. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X-L overexpression in motoneurons. Neurobiol. Dis. 42, 415\u2013426 (2011).","journal-title":"Neurobiol. Dis."},{"key":"2688_CR24","volume":"6","author":"ZW Du","year":"2015","unstructured":"Du, Z. W. et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 6, 6626 (2015).","journal-title":"Nat. Commun."},{"key":"2688_CR25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1042\/bj3190683","volume":"319","author":"R Nath","year":"1996","unstructured":"Nath, R. et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319, 683\u2013690 (1996).","journal-title":"Biochem. J."},{"key":"2688_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mcn.2014.06.006","volume":"61","author":"SK Custer","year":"2014","unstructured":"Custer, S. K. & Androphy, E. J. Autophagy dysregulation in cell culture and animals models of spinal muscular atrophy. Mol. Cell Neurosci. 61, 133\u2013140 (2014).","journal-title":"Mol. Cell Neurosci."},{"key":"2688_CR27","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.209","volume":"4","author":"A Garcera","year":"2013","unstructured":"Garcera, A., Bahi, N., Periyakaruppiah, A., Arumugam, S. & Soler, R. M. Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro. Cell Death Dis. 4, e686 (2013).","journal-title":"Cell Death Dis."},{"key":"2688_CR28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.expneurol.2016.06.032","volume":"283","author":"A Periyakaruppiah","year":"2016","unstructured":"Periyakaruppiah, A. et al. Autophagy modulators regulate survival motor neuron protein stability in motoneurons. Exp. Neurol. 283, 287\u2013297 (2016).","journal-title":"Exp. Neurol."},{"key":"2688_CR29","volume":"6","author":"D Park","year":"2016","unstructured":"Park, D. et al. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci. Rep. 6, 21772 (2016).","journal-title":"Sci. Rep."},{"key":"2688_CR30","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A. & Rubinsztein, D. C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 282, 5641\u20135652 (2007).","journal-title":"J. Biol. Chem."},{"key":"2688_CR31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fnmol.2018.00308","volume":"11","author":"R Schellino","year":"2018","unstructured":"Schellino, R., Boido, M., Borsello, T. & Vercelli, A. Pharmacological c-Jun NH. Front. Mol. Neurosci. 11, 308 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"2688_CR32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1389202919666180101154916","volume":"19","author":"MA Maretina","year":"2018","unstructured":"Maretina, M. A. et al. Molecular factors involved in spinal muscular atrophy pathways as possible disease-modifying candidates. Curr. Genomics 19, 339\u2013355 (2018).","journal-title":"Curr. Genomics"},{"key":"2688_CR33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jnc.13296","volume":"137","author":"AL Wright","year":"2016","unstructured":"Wright, A. L. & Vissel, B. CAST your vote: is calpain inhibition the answer to ALS? J. Neurochem. 137, 140\u2013141 (2016).","journal-title":"J. Neurochem."},{"key":"2688_CR34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll, D. E., Thompson, V. F., Li, H., Wei, W. & Cong, J. The calpain system. Physiol. Rev. 83, 731\u2013801 (2003).","journal-title":"Physiol. Rev."},{"key":"2688_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BJ20120921","volume":"447","author":"RL Campbell","year":"2012","unstructured":"Campbell, R. L. & Davies, P. L. Structure-function relationships in calpains. Biochem. J. 447, 335\u2013351 (2012).","journal-title":"Biochem. J."},{"key":"2688_CR36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1523\/JNEUROSCI.4496-09.2010","volume":"30","author":"R Ruiz","year":"2010","unstructured":"Ruiz, R., Casa\u00f1as, J. J., Torres-Benito, L., Cano, R. & Tabares, L. Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J. Neurosci. 30, 849\u2013857 (2010).","journal-title":"J. Neurosci."},{"key":"2688_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1083\/jcb.200703187","volume":"179","author":"S Jablonka","year":"2007","unstructured":"Jablonka, S., Beck, M., Lechner, B. D., Mayer, C. & Sendtner, M. Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy. J. Cell Biol. 179, 139\u2013149 (2007).","journal-title":"J. Cell Biol."},{"key":"2688_CR38","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1093\/hmg\/ddu112","volume":"23","author":"M Diepenbroek","year":"2014","unstructured":"Diepenbroek, M. et al. Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]\u03b1Syn transgenic mice. Hum. Mol. Genet. 23, 3975\u20133989 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"2688_CR39","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1523\/JNEUROSCI.1132-14.2014","volume":"34","author":"MV Rao","year":"2014","unstructured":"Rao, M. V. et al. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice. J. Neurosci. 34, 9222\u20139234 (2014).","journal-title":"J. Neurosci."},{"key":"2688_CR40","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/cdd.2014.151","volume":"22","author":"FM Menzies","year":"2015","unstructured":"Menzies, F. M. et al. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death Differ. 22, 433\u2013444 (2015).","journal-title":"Cell Death Differ."},{"key":"2688_CR41","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/hmg\/ddn234","volume":"17","author":"MP Walker","year":"2008","unstructured":"Walker, M. P. et al. SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum. Mol. Genet. 17, 3399\u20133410 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"2688_CR42","doi-asserted-by":"crossref","first-page":"e15769","DOI":"10.1371\/journal.pone.0015769","volume":"5","author":"JL Fuentes","year":"2010","unstructured":"Fuentes, J. L., Strayer, M. S. & Matera, A. G. Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain. PLoS ONE 5, e15769 (2010).","journal-title":"PLoS ONE"},{"key":"2688_CR43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams, A. et al. Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295\u2013305 (2008).","journal-title":"Nat. Chem. Biol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2688-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:11:05Z","timestamp":1670253065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2688-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["2688"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2688-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"487"}}